Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Lymphoma

Free Subscription Articles published in Leukemia Retrieve available abstracts of 86 articles: HTML format

Single Articles

June 2009
1. GASPERINI P , Tosato G
   Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. SCHWINDT H , Vater I, Kreuz M, Montesinos-Rongen M, et al
   Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. GELEBART P , Zak Z, Anand M, Dien-Bard J, et al
   Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   May 2009
4. KANELLIS G , Roncador G, Arribas A, Mollejo M, et al
   Identification of MNDA as a new marker for nodal marginal zone lymphoma.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. BAUS D , Nonnenmacher F, Jankowski S, Doring C, et al
   STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   
6. RENOUF B , Hollville E, Pujals A, Tetaud C, et al
   Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   
7. COPPO P , Gouilleux-Gruart V, Huang Y, Bouhlal H, et al
   STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.
   Leukemia. 2009.
   PubMed     Related articles    Abstract available
   
   
   
8. CARBONNELLE-PUSCIAN A , Copie-Bergman C, Baia M, Martin-Garcia N, et al
   The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.
   Leukemia. 2009;23:952-60.
   PubMed     Related articles    Abstract available
   
   
   April 2009
9. ROSATI A , Di Salle E, Luberto L, Quinto I, et al
   Identification of a Btk-BAG3 complex induced by oxidative stress.
   Leukemia. 2009;23:823-4.
   PubMed     Related articles   
   
   
   March 2009
10. ZHANG QL , Wang L, Zhang YW, Jiang XX, et al
    The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. KNECHT H , Sawan B, Lichtensztejn D, Lemieux B, et al
    The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells.
    Leukemia. 2009;23:565-73.
    PubMed     Related articles    Abstract available
    
    
    
12. FELDMAN AL , Law M, Remstein ED, Macon WR, et al
    Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
    Leukemia. 2009;23:574-80.
    PubMed     Related articles    Abstract available
    
    
    
13. STRUSKI S , Gervais C, Helias C, Herbrecht R, et al
    Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
    Leukemia. 2009;23:617-9.
    PubMed     Related articles   
    
    
    February 2009
14. WOYACH JA , Lin TS, Lucas MS, Heerema N, et al
    A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. DRAKOS E , Atsaves V, Li J, Leventaki V, et al
    Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. WANG M , Sun L, Qian J, Han X, et al
    Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. CHEUNG MC , Bailey D, Pennell N, Imrie KR, et al
    In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node.
    Leukemia. 2009.
    PubMed     Related articles   
    
    
    
18. FARINA L , Bruno B, Patriarca F, Spina F, et al
    The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
19. SANDLUND JT , Pui CH, Zhou Y, Behm FG, et al
    Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
20. MUSSOLIN L , Bonvini P, Ait-Tahar K, Pillon M, et al
    Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.
    Leukemia. 2009;23:400-2.
    PubMed     Related articles   
    
    
    January 2009
21. ROSSI D , Rasi S, Franceschetti S, Capello D, et al
    Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    
22. NIITSU N , Okamoto M, Miura I, Hirano M, et al
    Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations.
    Leukemia. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
23. KREJSGAARD T , Gjerdrum LM, Ralfkiaer E, Lauenborg B, et al
    Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome.
    Leukemia. 2008;22:2230-9.
    PubMed     Related articles    Abstract available
    
    
    
24. SWORDS R , O'Rafferty C, Giles F, Browne P, et al
    Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
    Leukemia. 2008;22:2277-8.
    PubMed     Related articles   
    
    
    November 2008
25. POIREL HA , Cairo MS, Heerema NA, Swansbury J, et al
    Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
26. LU P , Yang C, Guasparri I, Harrington W, et al
    Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma.
    Leukemia. 2008.
    PubMed     Related articles   
    
    
    
27. XHAARD A , Porcher R, Chien JW, de Latour RP, et al
    Impact of comorbidity indexes on non-relapse mortality.
    Leukemia. 2008;22:2062-9.
    PubMed     Related articles    Abstract available
    
    
    October 2008
28. BOERMA EG , Siebert R, Kluin PM, Baudis M, et al
    Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
29. LWIN T , Crespo LA, Wu A, Dessureault S, et al
    Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
30. WANG SS , Maurer MJ, Morton LM, Habermann TM, et al
    Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Leukemia. 2008.
    PubMed     Related articles   
    
    
    
31. KOZAKO T , Yoshimitsu M, Fujiwara H, Masamoto I, et al
    PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
32. OTZ T , Grosse-Hovest L, Hofmann M, Rammensee HG, et al
    A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells.
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
33. CHRISTOPOULOS P , Follo M, Fisch P, Veelken H, et al
    The peripheral helper T-cell repertoire in untreated indolent B-cell lymphomas: evidence for antigen-driven lymphomagenesis.
    Leukemia. 2008;22:1952-4.
    PubMed     Related articles   
    
    
    September 2008
34. BUSKE C , Hoster E, Dreyling M, Eimermacher H, et al
    The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Gr
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
35. BENTINK S , Wessendorf S, Schwaenen C, Rosolowski M, et al
    Pathway activation patterns in diffuse large B-cell lymphomas.
    Leukemia. 2008;22:1746-54.
    PubMed     Related articles    Abstract available
    
    
    August 2008
36. KLAPPER W , Stoecklein H, Zeynalova S, Ott G, et al
    Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
37. KLIER M , Anastasov N, Hermann A, Meindl T, et al
    Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
    Leukemia. 2008.
    PubMed     Related articles    Abstract available
    
    
    
38. PARRENS M , Gachard N, Petit B, Marfak A, et al
    Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories.
    Leukemia. 2008;22:1621-4.
    PubMed     Related articles   
    
    
    July 2008
39. FUJIWARA SI , Yamashita Y, Nakamura N, Choi YL, et al
    High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. JAIS JP , Haioun C, Molina TJ, Rickman DS, et al
    The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. YANG C , Lu P, Lee FY, Chadburn A, et al
    Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. PEREZ-GALAN P , Roue G, Lopez-Guerra M, Nguyen M, et al
    BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. LAWRIE CH , Saunders NJ, Soneji S, Palazzo S, et al
    MicroRNA expression in lymphocyte development and malignancy.
    Leukemia. 2008;22:1440-6.
    PubMed     Related articles   
    
    
    June 2008
44. FELDMAN AL , Sun DX, Law ME, Novak AJ, et al
    Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.
    Leukemia. 2008;22:1139-43.
    PubMed     Related articles    Abstract available
    
    
    
45. SOLER G , Radford-Weiss I, Ben-Abdelali R, Mahlaoui N, et al
    Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.
    Leukemia. 2008;22:1278-80.
    PubMed     Related articles   
    
    
    
46. SCHNEIDER B , Nagel S, Kaufmann M, Winkelmann S, et al
    T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29.
    Leukemia. 2008;22:1262-6.
    PubMed     Related articles   
    
    
    May 2008
47. BARD JD , Gelebart P, Anand M, Amin HM, et al
    Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK(+) anaplastic large cell lymphoma.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. BISHTON MJ , Hicks RJ, Prince HM, Ritchie DS, et al
    Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
49. PORRATA LF , Ristow K, Witzig TE, Tuinistra N, et al
    Reply to 'Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independence data set' by Mark J Bishton et al.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
50. JUNDT F , Acikgoz O, Kwon SH, Schwarzer R, et al
    Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. BALASUBRAMANIAN S , Ramos J, Luo W, Sirisawad M, et al
    A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas.
    Leukemia. 2008;22:1026-34.
    PubMed     Related articles    Abstract available
    
    
    
52. BERTRAND P , Maingonnat C, Picquenot JM, Dastugue N, et al
    Characterization of three t(3;8)(q27;q24) translocations from diffuse large B-cell lymphomas.
    Leukemia. 2008;22:1064-7.
    PubMed     Related articles   
    
    
    April 2008
53. RITZ O , Guiter C, Dorsch K, Dusanter-Fourt I, et al
    STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-Cell lymphoma.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
54. EHLERS A , Oker E, Bentink S, Lenze D, et al
    Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.
    Leukemia. 2008;22:835-41.
    PubMed     Related articles    Abstract available
    
    
    March 2008
55. USHMOROV A , Leithauser F, Ritz O, Barth TF, et al
    ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
56. ZHANG T , Nie K, Tam W
    BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
57. BERNARDESCHI P , Fiorentini G, Dentico P, Rossi S, et al
    Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
58. HAGENBEEK TJ , Spits H
    T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.
    Leukemia. 2008;22:608-19.
    PubMed     Related articles    Abstract available
    
    
    
59. HENRICH S , Christopherson RI
    Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.
    Leukemia. 2008;22:657-60.
    PubMed     Related articles   
    
    
    February 2008
60. HIWARKAR P , Arkenau HT, Treleaven J, Morgan G, et al
    The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
61. PIKE BL , Greiner TC, Wang X, Weisenburger DD, et al
    DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. MONTESINOS-RONGEN M , Brunn A, Bentink S, Basso K, et al
    Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
    Leukemia. 2008;22:400-5.
    PubMed     Related articles    Abstract available
    
    
    January 2008
63. STAMATOPOULOS K , Papadaki T, Pontikoglou C, Athanasiadou I, et al
    Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
64. MATTEUCCI C , Bracci M, Barba G, Carbonari M, et al
    Different genomic imbalances in low- and high-grade HCV-related lymphomas.
    Leukemia. 2008;22:219-22.
    PubMed     Related articles   
    
    
    December 2007
65. MATUTES E , Oscier D, Montalban C, Berger F, et al
    Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. HADDAD L , El Hajj H, Abou-Merhi R, Kfoury Y, et al
    KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. TAKAKUWA T , Tresnasari K, Rahadiani N, Miwa H, et al
    Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. WESSENDORF S , Barth TF, Viardot A, Mueller A, et al
    Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).
    Leukemia. 2007;21:2463-9.
    PubMed     Related articles    Abstract available
    
    
    
69. HUMENIUK R , Menon LG, Mishra PJ, Saydam G, et al
    Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.
    Leukemia. 2007;21:2399-405.
    PubMed     Related articles    Abstract available
    
    
    
70. GJERDRUM LM , Woetmann A, Odum N, Burton CM, et al
    FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Leukemia. 2007;21:2512-8.
    PubMed     Related articles    Abstract available
    
    
    
71. RUIZ-BALLESTEROS E , Mollejo M, Mateo M, Algara P, et al
    MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Leukemia. 2007;21:2547-9.
    PubMed     Related articles   
    
    
    
72. REDDICONTO G , Chiusolo P, Fiorini A, Farina G, et al
    Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.
    Leukemia. 2007;21:2552-4.
    PubMed     Related articles   
    
    
    
73. PORRATA LF , Ristow K, Witzig TE, Tuinistra N, et al
    Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.
    Leukemia. 2007;21:2554-6.
    PubMed     Related articles   
    
    
    November 2007
74. BOOKEN N , Gratchev A, Utikal J, Weiss C, et al
    Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. KRATZ CP , Niemeyer CM, Juttner E, Kartal M, et al
    Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with cafe-au-lait spots caused by a novel homozygous PMS2 mutation.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
76. REMSTEIN ED , Law M, Mollejo M, Piris MA, et al
    The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
77. NAGEL S , Leich E, Quentmeier H, Meyer C, et al
    Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. SANDA T , Okamoto T, Uchida Y, Nakagawa H, et al
    Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells.
    Leukemia. 2007;21:2344-53.
    PubMed     Related articles    Abstract available
    
    
    
79. OSTROVSKY O , Korostishevsky M, Levite I, Leiba M, et al
    Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
    Leukemia. 2007;21:2296-303.
    PubMed     Related articles    Abstract available
    
    
    
80. CORRADINI P , Dodero A, Farina L, Fanin R, et al
    Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.
    Leukemia. 2007;21:2316-23.
    PubMed     Related articles    Abstract available
    
    
    October 2007
81. LORENZO BERMEJO J , Sundquist J, Hemminki K
    Effect of parental history of cancer on the development of second neoplasms after lymphoma at the same site than the parents.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
82. NIEMANN CU , Kjeldsen L, Ralfkiaer E, Jensen MK, et al
    Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. DINGLI D , Russell SJ
    Mouse models and the RANKL/OPG axis in myeloma bone disease.
    Leukemia. 2007;21:2090-3.
    PubMed     Related articles   
    
    
    
84. RABIN N , Kyriakou C, Coulton L, Gallagher OM, et al
    A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer.
    Leukemia. 2007;21:2181-91.
    PubMed     Related articles    Abstract available
    
    
    
85. GUIDOLIN D , Nico B, Belloni AS, Nussdorfer GG, et al
    Morphometry and mathematical modelling of the capillary-like patterns formed in vitro by bone marrow macrophages of patients with multiple myeloma.
    Leukemia. 2007;21:2201-3.
    PubMed     Related articles   
    
    
    May 2007
86. TSE E , Chan JC, Pang A, Au WY, et al
    Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: